E Squared Investments in South African medtech deal
E Squared Investments, along with ANZA Capital, have invested in Impulse Biomedical, a Cape Town-based medtech startup.
** For the best experience, download the free Africa Private Equity News app Android | iOS **
E Squared Investments, along with ANZA Capital, have invested in Impulse Biomedical, a Cape Town-based medtech startup.
Founded by engineering entrepreneurs Giancarlo Beukes and Gokul Nair, Impulse Biomedical develops medical devices aimed at improving emergency care. Its products include the Easy Squeezy, a low-cost, user-friendly asthma inhaler designed to help patients manage their condition more easily, and the ZiBiPen, a reloadable epinephrine auto-injector intended as a more affordable and sustainable alternative to single-use versions.
“At E Squared, we back scalable ventures that create both commercial value and measurable social impact,” said Pyi Maung, head of investments at E Squared Investments. “Impulse Biomedical’s mission and innovation represent the kind of purpose-driven entrepreneurship South Africa and the world needs.”
“This partnership marks a pivotal step in our journey to deliver accessible, life-saving healthcare at scale,” said Giancarlo Beukes, co-founder of Impulse Biomedical. “With a shared passion for impact, progress and a better tomorrow, we are excited to work with E Squared to place our innovations – present and future – in the hands of people around the world.”
Stay ahead in Africa's private equity and venture capital sector with Africa Private Equity News’ monthly Dealmaker’s Log – a database of reported investment deals, exits, and fundraising closes. Subscribe here